Navigation Links
Avanir Pharmaceuticals to Present at Three Conferences in March
Date:2/23/2011

ALISO VIEJO, Calif., Feb. 23, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced that company management will present an overview of the company at the following conferences in March.

  • Citi 2011 Global Healthcare Conference
    • Location: Hilton New York, New York, NY
    • Presentation date: Tuesday March 1, 2011
    • Presentation time: 8:00am ET

  • Cowen & Company Healthcare Conference
    • Location: Boston Marriott, Boston, MA
    • Presentation date: Tuesday March 8, 2011
    • Presentation time: 8:45am ET

  • 2011 Roth OC Growth Conference
    • Location: The Ritz Carlton, Laguna Niguel, CA
    • Presentation date: Monday March 14, 2011
    • Presentation time: 5:00pm PT

A live webcast and 30-day archive of these presentations will be available at http://www.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR™ and NUEDEXTA™ are trademarks owned by Avanir Pharmaceuticals, Inc.

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and increase market presence. ... ... ... ... Sino-German High-Tech ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
(Date:5/3/2016)... , May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is ... a video of two patients who tell their personal story and encourage those at risk ... Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... May 03, 2016 , ... Calvary Hospital recently hosted a ... Hospice (DGH), a 10-bed unit located at Mary, Manning Walsh Home (MMW) in Manhattan. ... performs at DGH for half an hour, once a week. The music brings a ...
(Date:5/3/2016)... ... May 03, 2016 , ... Sandbox, one of ... to serve in the newly created position of executive vice president, chief creative ... efforts in the Chicago and LA offices. He reports to Nancy Finigan, president ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... has announced today the launch of its Associates and Bachelor's degrees in Health ... of The Rockefeller University, Dr. Torsten N. Wiesel; Chairman and CEO of Fortune ...
(Date:5/3/2016)... , ... May 03, 2016 , ... Each year, about ... cause of death across the United States and account for one death every four ... impairments or are permanently disabled. HCR ManorCare is launching a video series called “Your ...
(Date:5/3/2016)... ON (PRWEB) , ... May 03, 2016 , ... ... recognized as one of Canada’s top Information and Communication Technology (ICT) companies in ... Canadian and Multinational ICT companies operating in Canada, as ranked by revenue. ...
Breaking Medicine News(10 mins):